Full View

In vitro Selection of Resistance to Sofosbuvir in HCV Replicons of Genotype-1 to -6

S Xu, B Doehle, S Rajyaguru, B Han… - Antiviral …, 2017 - journals.sagepub.com
Background Sofosbuvir is a nucleoside analogue inhibitor of the HCV NS5B polymerase
approved for treatment of HCV-infected patients in combination with ribavirin or with other …
被引用次数：38 相关文章

In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to-6.

S Xu, B Doehle, S Rajyaguru, B Han, O Barauskas… - Antiviral …, 2017 - europepmc.org
Background Sofosbuvir is a nucleoside analogue inhibitor of the HCV NS5B polymerase
approved for treatment of HCV-infected patients in combination with ribavirin or with other …

In vitro Selection of Resistance to Sofosbuvir in HCV Replicons of Genotype-1 to -6

S Xu, B Doehle, S Rajyaguru, B Han, O Barauskas… - Antiviral …, 2016 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> Sofosbuvir is a nucleoside
analogue inhibitor of the HCV NS5B polymerase approved for treatment of HCV-infected …

In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to-6

S Xu, B Doehle, S Rajyaguru, B Han… - Antiviral …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Sofosbuvir is a nucleoside analogue inhibitor of the HCV NS5B polymerase
approved for treatment of HCV-infected patients in combination with ribavirin or with other …